Satisfaction among users (therapists and doctors) and patients with LuXXaMed
As part of our PMCF study, we would like to share with you a new assessment of user and patient satisfaction with LuXXaMed therapy.
PMCF (Post-Market Clinical Follow-up) is a legal requirement under which manufacturers of medical devices must continuously evaluate the performance of their products. A PMCF is a legal and regulatory requirement for all manufacturers in the European Union.
As we have nothing to hide and maintain a transparent relationship with our customers, we publish our results regularly and are open to any criticism or questions.
Direct assessment of satisfaction amongst a representative sample group
The 85% satisfaction rate relates to individual treatments, which the study group β comprising 15 participants (doctors, physiotherapists and alternative practitioners) β regularly reports via a questionnaire.
This survey covers the period from 1 July 2019 to 18 February 2020 and was based on 673 questionnaires or treatment sessions.
On average, users and patients rated their satisfaction with LuXXaMed therapy at 6 out of 7 points.
